Joo-Ohn Sohn

Oncologic Safety of Gonadotropin‐Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy

W. Han, S. Ahn, J. Lee, 2018, Clinical breast cancer.

Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18–14/KM10B)

Min Hwan Kim, Yeon-Hee Park, J. Byun, 2022, Breast.

Effect of Tooth-brushing on Oral Health and Ventilator-Associated Pneumonia of Critically III Patients

M. Son, E. Oh, Ah-Ram Kim, 2011 .

Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer

Seul-Gi Kim, Joo-Ohn Sohn, Sa Deok Hong, 2023, Journal of Experimental & Clinical Cancer Research.

Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation

G. Kim, Jeong Dong Lee, W. Ryu, 2024, Experimental & molecular medicine.